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Abstract
Background: As a multisystem infectious disease, there is an inflammation, which causes increase in acute phase
reactants in brucellosis. The mean platelet volume (MPV), platelet distribution width (PDW), red cell distribution
width (RDW), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have been identified as
markers of inflammation. The present study aimed to evaluate diagnostic values of these biomarkers in brucella
arthritis (BA).
Methods: The study included 64 children with BA and 66 healthy control subjects. Demographic features, joint
involvement, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and hematological variables were
retrospectively recorded. In addition, results of synovial fluid and serum tube agglutination test for brucella together
with treatment regimens were recorded.
Results: The mean age of the patients (53.1 % male) was 92.3 ± 41.2 months. The most commonly affected joint
was ankle (53.1 %). Synovial fluid puncture-brucella agglutination test was positive in 22 (34.3 %) patients. Puncture
culture was positive in 9 patients. Most of the patients (57.8 %) were treated with a combination of rifampicin plus
sulfamethoxazole/trimethoprim and gentamicin. Significantly higher mean PDW, RDW, MPV, NLR and PLR values
were found in children with BA compared to control subjects (p < 0.05). A positive correlation was found between
MPV and NLR values (R2 = 0.192, p < 0.001).
Conclusion: Our findings indicated that NLR and PLR are indirect markers of inflammation that may be observed
abnormally increased in children with brucella arthritis. Further longitudinal studies are needed to investigate this
topic to establish the more clear associations.
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Background
Brucellosis, the most common bacterial zoonosis in the
world, is still endemic in many developing countries.
The clinical presentation of brucellosis is non-specific
and the course and the severity of infection is variable;
in humans, it presents as a multisystem disease involving
many organs and tissues [1]. Fever and arthritis are the
most common signs. Osteoarticular involvement is one
of the most frequent complications of brucellosis. Al-
though in adults with osteoarticular brucellosis due to
Brucella abortus from Northwestern Spain sacroiliitis
and spondylitis were more common than peripheral
arthritis [2], monoarthritis is now considered as the pre-
dominant musculoskeletal manifestation of brucellosis
[3, 4]. The most commonly affected joints are the hip
and the knee. Unlike in adults, the sacroiliac joint and
the axial skeleton are rarely affected. Monoarthritis is
more common than polyarthritis. This may lead to con-
fusion with pyogenic arthritis in children; therefore, in a
community where brucella is common, awareness about
this entity should prompt the investigation of this
disease, and physicians should have a high index of
suspicion for brucella arthritis (BA) [5].
Laboratory findings may be normal in some pediatric
cases of brucella arthritis; however, it is not possible to
take synovial fluid from all of these patients. Therefore,
* Correspondence: fesihaktar@yahoo.com
1Department of Pediatric Infectious Disease, Dicle University School of
Medicine, 21280 Diyarbakir, Turkey
Full list of author information is available at the end of the article
© 2016 Aktar et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Aktar et al. Italian Journal of Pediatrics  (2016) 42:3 
DOI 10.1186/s13052-016-0211-5
new inflammatory markers are required in diagnosis of
pediatric BA patients. There are few previous studies on
the parameters indicating new inflammatory markers in
pediatric brucella arthritis. The present study aimed to
investigate the levels of MPV, PDW, RDW, NLR and
PLR as possible indirect inflammatory markers in chil-
dren with brucella arthritis.
Methods
This retrospective study was performed by the two
center of medical faculty of university pediatric
clinics. The medical records of all patients with BA
between November 2011 and January 2014 were
obtained from the hospital records. A total of 64
children with BA and 66 age- and gender-matched
healthy controls were enrolled in the study.
Healthy subjects were children who applied to hospital
for routine check-up or for preoperative evaluation of
minor elective surgery such as circumcision or hernia
repair. Control group subjects were recruited from
hospital records of these children. Children with any
sign of infection or systemic illness were excluded from
the control group.
Arthritis occurred for the first time in all patients
within the week before admission to hospital. The diag-
nosis of arthritis was made if the subjects had joint pain,
restriction of movement, and swelling. Swelling was not
essential for the diagnosis of hip, spine, or sacroiliac
arthritis. Although encountered in many cases, add-
itional signs such as effusion, redness and increased
temperature on joint were not considered essential for
the diagnosis of arthritis.
The diagnosis of brucellosis with joint involvement
was established according to the presence of all of the
following criteria; a clinical picture compatible with arth-
ritis, isolation of Brucella from blood or synovial fluids,
positive brucella serology test 1:≥160, using the Standard
Agglutination Test (SAT) for patients presenting with
symptoms suggestive of brucellosis. For screening and in
the absence of clinical indicators of active brucellosis, a
titer of 1:320 or higher is more specific for the presence
of the disease. Pediatric patients with a synovial fluid
culture positive for brucella and available results of the
cytological examination of the synovial fluid aspirate
were identified. Relevant demographic, clinical and labora-
tory data, and treatment modalities and outcomes were
obtained from patients’ follow-up cards and hospital
records.
Hemogram parameters including white blood cell
(WBC) count, neutrophil count, lymphocyte count,
hemoglobin (Hb), platelet count (PLT), platelet distribu-
tion width (PDW), red cell distribution width (RDW),
mean platelet volume (MPV), neutrophil to lymphocyte
ratio (NLR) and platelet to lymphocyte ratio (PLR) were
assessed. C-reactive protein (CRP), erythrocyte sedimen-
tation rate (ESR), agglutination assay and culture for
both blood and joint puncture at admission were also
recorded.
NLR and PLR were calculated as the ratio of neutro-
phils to lymphocytes and platelets to lymphocytes, re-
spectively. These hematological variables were measured
and recorded in the healthy control subjects as well.
Comparison between the study and the control subjects
was performed with regards to WBC, neutrophil count,
lymphocyte count, PDW, RDW, PLT, MPV, NLR and
PLR. Blood samples were obtained using a vacutainer
and collected in tubes containing standard EDTA. All
blood samples were tested for hematological parameters
using the same regularly calibrated analyzer (Abbott
CELL-DYN 3700, United States).
Joint fluid was aspirated from the affected joint follow-
ing a strict sterile technique. Since usually only small
amounts of fluid were obtained, the synovial fluid speci-
mens were only sent for cytological and bacteriological
examination, and tested for antibrucella antibodies using
microagglutination test.
WBC, Hb, neutrophil count, lymphocyte count, PLT,
MPV, NLR and PLR values were compared between the
study and the control groups.
Patients with a clear-cut underlying pathology like vari-
ous bone and joint diseases, connective tissue, rheumatic
disorders, chronic disorders, anemia or other hematological
diseases, acute bacterial infection as well as fever of other
etiologies, who were over 18 years old and whose file re-
cords were inaccessible, were excluded from the study.
The Non-Interventional Clinical Ethics Committee of
Dicle University Medical Faculty approved the study
protocol.
Statistical analysis
The normality of data distribution was determined using
the Kolmogorov-Smirnov test. Normally distributed numer-
ical variables were expressed in mean plus/minus standard
deviation. Normally distributed numeric variables were
compared using the Student’s t-test or One-way ANOVA
test. Data corresponding to an abnormal distribution were
compared using the non-parametric Mann–Whitney U-test
or Kruskal-Wallis test. The Chi-square test was used to
compare categorical variables between the groups. Correla-
tions between numerical variables were evaluated using
Pearson’s or Spearman’s correlation analysis. P-values of less
than 0.05 were considered statistically significant. The data
were analyzed using Statistical Package for Social Sciences
(SPSS) version 18.0 program for Windows.
Results
The mean age of the patients was 92.3 ± 41.2 months
and 53.1 % (n = 34) of the patients were male. The mean
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age of the control group was 98.5 ± 44.0 months and
53 % (n = 35) were male. There were no significant dif-
ferences in the mean age and gender distribution
between the study and the control groups (p > 0.05).
The median duration of hospitalization was 6 (2–76)
days in patients with BA. Five (7.8 %) patients had
hepatomegaly, 15 (23.4 %) had splenomegaly and five
(7.8 %) had hepatosplenomegaly. The most common
symptoms at admission were arthralgia, joint pain and
fever. The most commonly affected joint was ankle
(n = 34, 53.1 %). Most of the patients (n = 37, 57.8 %)
were treated with a combination of rifampicin plus
sulfamethoxazole/trimethoprim and gentamicin. Synovial
fluid puncture was performed in 24 (37.5 %) patients and
brucella agglutination test was found positive in 22
(34.3 %) patients. Puncture culture was positive in nine
(14 %) patients. The average ESR was 40.9 ± 20.4 mm/h
and the mean CRP level was 28.1 ± 22.4 mg/L in patients
with BA (Table 1).
Median WBC was 10.0 ± 4.2 × 103/ml, PDW was ± 3.0,
RDW was 16.2 ± 1.4, MPV value was 8.2 fL (6.3–11),
NLR was 4.1 (1–13) and PLR was 154 (9.3–497) in the
patient group. The patient group had significantly higher
WBC, neutrophil count, PDW, RDW, MPV, NLR, PLR
and lower lymphocyte and platelet counts at admission,
compared to the control group (p < 0.05) (Table 2).
There was a positive correlation between MPV and NLR
(R2 = 0.192, p < 0.001) (Fig. 1). No correlation was found
between MPV, ESR and CRP values.
Discussion
Although hematological changes are common in bru-
cella arthritis, they are not diagnostic and usually do not
require treatment. In childhood brucella arthritis,
hematological disorders may occur as leukocytosis,
anemia, relative lymphocytosis along with leukopenia,
thrombocytopenia and pancytopenia [6]. The study by
El-Koumi et al. found anemia in 43 %, leukopenia in
38 %, leukocytosis in 20 % and pancytopenia in 18 % of
the cases [7]. Similar to the previous studies, the present
study found anemia in 45.3 %, thrombocytopenia in
21.8 %, leukopenia in 10.9 %, leukocytosis in 9.3 % and
pancytopenia in 7.8 % of the patients. Significantly
higher leukocyte and neutrophil counts were found in
brucellosis patients compared to the control group,
whereas the lymphocyte and thrombocyte counts were
lower.
The present study aimed to investigate the predictive
contribution value of NLR, PLR and MPV in the diagno-
sis of BA. Our findings showed that NLR, PLR and MPV
were higher in patients with BA compared to the control
group.
NLR can be determined from routine blood differ-
entials at no additional cost. Changes in the relative
Table 1 Demographic and clinical characteristics and treatment
modalities in patients with Brucella arhtritis
Clinical features Mean ± SD, median range
or number (%) (n:64)




Duration of hospitalization (day) 6 (2–76)
Symptoms and clinical findings
Arthralgia 64 (100)






Restriction of movement 36 (56.2)
Diaphoresis 33 (51.6)
Swelling 22 (34.3)
Increase temperature on joint 22 (34.3)
Joint redness 22 (34.3)
Headache 20 (31.3)
Abdominal pain 14 (21.9)
Joint effusion 13 (20.3)
Chest pain 11 (17.2)





Erythrocyte sedimentation rate (mm/h) 40.9 ± 20.4







Joint puncture 4 (6.3)
Blood + Joint puncture 5 (7.9)
Treatment
Rifampicin + Tetracycline + Streptomycin 13 (20.3)
Rifampicin + Tetracycline + Gentamicin 14 (21.8)
Rifampicin + TMP-SMX + Gentamicin 37 (57.8)
TMP-SMX trimethoprim-sulfamethoxazole, SD standard deviation
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abundance of leukocyte subgroups occur in parallel
with the increase in overall leukocyte count. Lympho-
cyte count decreases when neutrophil count increases.
NLR increases in inflammatory conditions and this
increase is considered as an indicator of systemic in-
flammation [8]. Studies showed that platelets also play
an active role in inflammation, while having regulatory ef-
fects on the immune system [9]. The study by Günes et al.
[10] was conducted on patients with juvenil rheumatoid
arthritis (JRA) and demonstrated that NLR was higher in
patients with juvenile idiopathic arthritis compared with
the control group. In another study, significantly higher
NLR values were found in patients with ankylosing spon-
dylitis [11]. In the study by Türkmen et al., the PLR ratio
showed better performance than the NLR ratio in the pre-
diction of inflammation in patients with end-stage renal
disease [12]. As a result of changes caused by the in-
flammation in neutrophils, platelets and lymphocytes,
NLR and PLR have turned into inflammatory markers.
Based on the results of the present study and other
similar studies, we suggest that the NLR and PLR ratios
may be inflammatory markers that can be used in the
diagnosis and follow-up of the disease in children with
brucella arthritis.
Table 2 Laboratory findings of the study and control groups
Parameters Study group mean ± SD
or median range
Control group mean ± SD
or median range
p value
WBC (K/μL) 10.0 ± 4.2 8.25 ± 1.7 0.040
Neutrophil (103/μL) 7.10 (1.70-16.5) 3.98 (2.20-9.12) <0.001
Lymphocyte (103/μL) 1.60 (0.60-7.0) 2.92 (0.73-4.95) <0.001
Platelet count (K/μL) 282 ± 144 314 ± 65.7 <0.001
PDW,% 38,1 ± 3.0 23.0 ± 3.9 <0.001
RDW,% 16.2 ± 1.4 9.4 ± 1.8 <0.001
MPV (fl) 8.2 (6.3-11) 7.3 (5.7-12.3) 0.026
NLR 4.1 (1–13) 1.4 (0.6-10.8) <0.001
PLR 154 (9.3-497) 106 (50–525) <0.001
WBC white blood cell, PDW platelet distribution width, RDW red cell distribution width, MPV mean platelet volume, NLR neutrophil to lymphocyte ratio, PLR
platelet to lymphocyte ratio, SD standart deviation
Fig. 1 The relationship between mean platelet volume and neutrophil to lymphocyte ratio
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Hematologic abnormalities are observed in brucellosis.
One of these abnormalities is thrombocytopenia. Over
release of proinflammatory cytokines and acute-phase
reactants can suppress the size of platelets [8, 9]. The
study by Okan et al. found that MPV was statistically
significantly lower in brucellosis cases compared to
control group [9]. Küçükbayrak et al. and Bozkurt et al.
conducted studies on adult patients and established that
MPV was increased statistically after treatment in bru-
cellosis cases [13, 14]. The literature contains many
studies regarding several diseases related to MPV, PDW
and RDW, and a part of such studies demonstrated in-
creased MPV in acute coronary syndrome, diabetes melli-
tus, cerebrovascular conditions, preeclampsia, renal artery
stenosis, hypercholesterolemia, smoking and sepsis
[15–17]. However, there are few studies on brucellosis
cases. The present study found higher MPV, PDW and
RDW in brucella arthritis patients than control group.
Increased CRP and ESR have been reported to be in-
volved in active inflammation and are often considered as
useful criteria for the diagnosis and follow-up effectiveness
of treatment in brucella and other inflammatory condi-
tions [1, 17, 18]. The studies evaluating the correlation be-
tween MPV and CRP, ESR and SAT reported different
results. Kader et al. [19] found a significant negative cor-
relation between MPV and SAT. Öztürk et al. [20] found a
negative correlation between MPV and CRP, while two
studies found positive correlation between MPV and CRP
[21, 22]. The present study found a significant positive
correlation between NLR and MPV, whereas there was no
significant correlation between MPV, SAT, ESR and CRP.
Our study has several limitations. Firstly, it is a retro-
spective study with a relatively small sample size and
synovial fluid was not taken from all patients. It would
be very useful if we can compare the markers between
patients with brucella arthritis, septic arthritis and react-
ive arthritis. The studies with a larger number of pa-
tients and more comprehensive analyses can provide
further data on these variables.
Conclusion
MPV, PDW, RDW, NLR and PLR values can be useful
complementary indirect markers for diagnosis of BA in
children. We believe that these variables can be taken
into account as quick, cheap and easily measurable new
inflammatory markers in patients with BA. Further pro-
spective studies are required to externally cross-validate
our findings in larger cohorts of BA patients.
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